Guselkumab Beats Adalimumab for Moderate to Severe Psoriasis

Guselkumab is effective for treating patients with moderate to severe psoriasis, according to results from Janssen's VOYAGE 1 and VOYAGE 2 trials.
Reuters Health Information

http://ift.tt/2iyEIf1